ID   Tu 138
AC   CVCL_4910
SY   Tu-138; Tu138
DR   BioSample; SAMN03151956
DR   Wikidata; Q54973307
RX   PubMed=8033080;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764). Originally thought to originate from a gingivo-labial moderately differentiated squamous carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00428.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 8,9
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T20 ! T404
OI   CVCL_1T19 ! T406 [Human HNSCC]
OI   CVCL_1T17 ! Tu 158LN
OI   CVCL_4911 ! Tu 159
OI   CVCL_4914 ! Tu 182
OI   CVCL_4915 ! Tu 212
OI   CVCL_1T18 ! Tu 212LN
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
RX   PubMed=8033080;
RA   Liu, Ta-Jen
RA   Zhang, Wei-Wei
RA   Taylor, Dorothy L.
RA   Roth, Jack Alan
RA   Goepfert, Helmuth
RA   Clayman, Gary L.
RT   "Growth suppression of human head and neck cancer cells by the
RT   introduction of a wild-type p53 gene via a recombinant adenovirus.";
RL   Cancer Res. 54:3662-3667(1994).
//
RX   PubMed=21868764; DOI=10.1158/1078-0432.CCR-11-0690; PMCID=PMC3229662;
RA   Zhao, Mei
RA   Sano, Daisuke
RA   Pickering, Curtis R.
RA   Jasser, Samar A.
RA   Henderson, Ying C.
RA   Clayman, Gary L.
RA   Sturgis, Erich M.
RA   Ow, Thomas J.
RA   Lotan, Reuben
RA   Carey, Thomas E.
RA   Sacks, Peter G.
RA   Grandis, Jennifer Rubin
RA   Sidransky, David
RA   Heldin, Nils-Erik
RA   Myers, Jeffrey N.
RT   "Assembly and initial characterization of a panel of 85 genomically
RT   validated cell lines from diverse head and neck tumor sites.";
RL   Clin. Cancer Res. 17:7248-7264(2011).
//